Reid Hoffman has stepped down from Microsoft's board after a decade of service to focus on Manus, his AI-driven drug discovery startup. His time on the Microsoft board proved financially rewarding for the LinkedIn co-founder and venture capitalist.
The move represents a shift to what Hoffman calls "founder mode," allowing him to dedicate his attention to hands-on leadership of Manus rather than board governance responsibilities. The startup applies artificial intelligence to pharmaceutical research and development.